Literature DB >> 1371462

Thyroid expression of an A2 adenosine receptor transgene induces thyroid hyperplasia and hyperthyroidism.

C Ledent1, J E Dumont, G Vassart, M Parmentier.   

Abstract

Cyclic AMP (cAMP) is the major intracellular second messenger of thyrotropin (TSH) action on thyroid cells. It stimulates growth as well as the function and differentiation of cultured thyrocytes. The adenosine A2 receptor, which activates adenylyl cyclase via coupling to the stimulating G protein (Gs), has been shown to promote constitutive activation of the cAMP cascade when transfected into various cell types. In order to test whether the A2 receptor was able to function similarly in vivo and to investigate the possible consequences of permanent adenylyl cyclase activation in thyroid cells, lines of transgenic mice were generated expressing the canine A2 adenosine receptor under control of the bovine thyroglobulin gene promoter. Thyroid-specific expression of the A2 adenosine receptor transgene promoted gland hyperplasia and severe hyperthyroidism causing premature death of the animals. The resulting goitre represents a model of hyperfunctioning adenomas: it demonstrates that constitutive activation of the cAMP cascade in such differentiated epithelial cells is sufficient to stimulate autonomous and uncontrolled function and growth.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1371462      PMCID: PMC556484          DOI: 10.1002/j.1460-2075.1992.tb05084.x

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  32 in total

1.  Adenosine regulates via two different types of receptors, the accumulation of cyclic AMP in cultured brain cells.

Authors:  D van Calker; M Müller; B Hamprecht
Journal:  J Neurochem       Date:  1979-11       Impact factor: 5.372

2.  Analysis of single- and double-stranded nucleic acids on polyacrylamide and agarose gels by using glyoxal and acridine orange.

Authors:  G K McMaster; G G Carmichael
Journal:  Proc Natl Acad Sci U S A       Date:  1977-11       Impact factor: 11.205

3.  Modulation of thyroglobulin messenger RNA accumulation in the rat thyroid.

Authors:  N H Scherberg; G Vassart; R Lecocq; J E Dumont; S Refetoff
Journal:  Endocrinology       Date:  1981-11       Impact factor: 4.736

4.  A simplification of the protein assay method of Lowry et al. which is more generally applicable.

Authors:  G L Peterson
Journal:  Anal Biochem       Date:  1977-12       Impact factor: 3.365

5.  Functional expression of the human formyl peptide receptor in Xenopus oocytes requires a complementary human factor.

Authors:  P M Murphy; D McDermott
Journal:  J Biol Chem       Date:  1991-07-05       Impact factor: 5.157

6.  Thyroid adenocarcinomas secondary to tissue-specific expression of simian virus-40 large T-antigen in transgenic mice.

Authors:  C Ledent; J Dumont; G Vassart; M Parmentier
Journal:  Endocrinology       Date:  1991-09       Impact factor: 4.736

7.  Pituitary hyperplasia and gigantism in mice caused by a cholera toxin transgene.

Authors:  F H Burton; K W Hasel; F E Bloom; J G Sutcliffe
Journal:  Nature       Date:  1991-03-07       Impact factor: 49.962

8.  Mechanism of action of thioureylene antithyroid drugs: factors affecting intrathyroidal metabolism of propylthiouracil and methimazole in rats.

Authors:  T Nakashima; A Taurog; G Riesco
Journal:  Endocrinology       Date:  1978-12       Impact factor: 4.736

9.  Somatotroph hypoplasia and dwarfism in transgenic mice expressing a non-phosphorylatable CREB mutant.

Authors:  R S Struthers; W W Vale; C Arias; P E Sawchenko; M R Montminy
Journal:  Nature       Date:  1991-04-18       Impact factor: 49.962

10.  The orphan receptor cDNA RDC7 encodes an A1 adenosine receptor.

Authors:  F Libert; S N Schiffmann; A Lefort; M Parmentier; C Gérard; J E Dumont; J J Vanderhaeghen; G Vassart
Journal:  EMBO J       Date:  1991-07       Impact factor: 11.598

View more
  28 in total

Review 1.  Thyrotropin receptor mutations in thyroid diseases.

Authors:  P M Yen
Journal:  Rev Endocr Metab Disord       Date:  2000-01       Impact factor: 6.514

2.  Loss of p53 promotes anaplasia and local invasion in ret/PTC1-induced thyroid carcinomas.

Authors:  K M La Perle; S M Jhiang; C C Capen
Journal:  Am J Pathol       Date:  2000-08       Impact factor: 4.307

3.  Immunological identification of A2 adenosine receptors by two antipeptide antibody preparations.

Authors:  T M Palmer; K A Jacobson; G L Stiles
Journal:  Mol Pharmacol       Date:  1992-09       Impact factor: 4.436

4.  Deletion of Rap1b, but not Rap1a or Epac1, Reduces Protein Kinase A-Mediated Thyroid Cancer.

Authors:  Danielle J Huk; Amruta Ashtekar; Alexa Magner; Krista La Perle; Lawrence S Kirschner
Journal:  Thyroid       Date:  2018-08-02       Impact factor: 6.568

5.  Cyclic AMP inhibits the proliferation of thyroid carcinoma cell lines through regulation of CDK4 phosphorylation.

Authors:  Ana Sofia Rocha; Sabine Paternot; Katia Coulonval; Jacques E Dumont; Paula Soares; Pierre P Roger
Journal:  Mol Biol Cell       Date:  2008-09-17       Impact factor: 4.138

Review 6.  Molecular insights into TSH receptor abnormality and thyroid disease.

Authors:  D Russo; F Arturi; E Chiefari; S Filetti
Journal:  J Endocrinol Invest       Date:  1997-01       Impact factor: 4.256

Review 7.  Lessons from mouse models of thyroid cancer.

Authors:  Caroline S Kim; Xuguang Zhu
Journal:  Thyroid       Date:  2009-12       Impact factor: 6.568

8.  Intracellular cross-talk between thyrotropin receptor and A1 adenosine receptor in regulation of phospholipase C and adenylate cyclase in COS-7 cells transfected with their receptor genes.

Authors:  F Okajima; H Tomura; K Sho; M Akbar; M A Majid; Y Kondo
Journal:  Biochem J       Date:  1995-03-15       Impact factor: 3.857

9.  The DREAM protein is associated with thyroid enlargement and nodular development.

Authors:  Marcos Rivas; Britt Mellström; Begoña Torres; Gaetano Cali; Alfonso M Ferrara; Daniela Terracciano; Mariastella Zannini; Gabriella Morreale de Escobar; Jose R Naranjo
Journal:  Mol Endocrinol       Date:  2009-03-19

Review 10.  Modeling thyroid cancer in the mouse.

Authors:  X-G Zhu; S-Y Cheng
Journal:  Horm Metab Res       Date:  2009-04-08       Impact factor: 2.936

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.